Influenza Stocks List of Influenza Stocks Topbrokers Post date May 15, 2022 — 17:49 Post Lock Read More Investment hedging guide: OPEC lowered its forecast for global oil demand in 2022, Mingde Bio will welcome a huge lifting of the ban, and Tahoe Smart shareholders plan to reduce their holdings by no more than 5.5% Post date May 13, 2022 — 10:32 Post Lock Read More Poinsettia: The company's vaccine pipeline products include 7 products including quadrivalent influenza vaccine and RSV vaccine Post date May 12, 2022 — 12:20 Post Lock Read More Poinsettia: The company's vaccine pipeline products include 7 products including quadrivalent influenza vaccine and RSV vaccine. Post date May 12, 2022 — 12:04 Post Lock Read More The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached) Post date May 11, 2022 — 20:43 Post Lock Read More Announcement at noon on May 9: A wholly-owned subsidiary of Poinsettia obtained the registration certificate of venlafaxine hydrochloride sustained-release capsules Post date May 9, 2022 — 12:09 Post Lock Read More Poinsettia (300723.SZ) has repurchased 5,081,700 shares at a cost of 146 million yuan Post date May 5, 2022 — 17:54 Post Lock Read More Poinsettia (300723.SZ) has repurchased 5,081,700 shares at a cost of 146 million yuan Post date May 5, 2022 — 17:50 Post Lock Read More Poinsettia (300723): Progress of share repurchase- CFi.CN Zhongcai Network Post date May 5, 2022 — 17:46 Post Lock Read More Poinsettia (300723): Part of the company's actual controller's shares have been released from pledge and re-pledged CFi.CN Zhongcai Network Post date May 5, 2022 — 17:45 Post Lock Read More Fangyuan shares (688148): Fangyuan shares on the general election of the board of directors and the board of supervisors- CFi.CN Zhongcai Network Post date April 28, 2022 — 10:26 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine Post date April 27, 2022 — 13:26 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine. Post date April 27, 2022 — 13:16 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine – yqqlm Post date April 27, 2022 — 13:15 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Investment hedging guide: OPEC lowered its forecast for global oil demand in 2022, Mingde Bio will welcome a huge lifting of the ban, and Tahoe Smart shareholders plan to reduce their holdings by no more than 5.5% Post date May 13, 2022 — 10:32 Post Lock Read More Poinsettia: The company's vaccine pipeline products include 7 products including quadrivalent influenza vaccine and RSV vaccine Post date May 12, 2022 — 12:20 Post Lock Read More Poinsettia: The company's vaccine pipeline products include 7 products including quadrivalent influenza vaccine and RSV vaccine. Post date May 12, 2022 — 12:04 Post Lock Read More The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached) Post date May 11, 2022 — 20:43 Post Lock Read More Announcement at noon on May 9: A wholly-owned subsidiary of Poinsettia obtained the registration certificate of venlafaxine hydrochloride sustained-release capsules Post date May 9, 2022 — 12:09 Post Lock Read More Poinsettia (300723.SZ) has repurchased 5,081,700 shares at a cost of 146 million yuan Post date May 5, 2022 — 17:54 Post Lock Read More Poinsettia (300723.SZ) has repurchased 5,081,700 shares at a cost of 146 million yuan Post date May 5, 2022 — 17:50 Post Lock Read More Poinsettia (300723): Progress of share repurchase- CFi.CN Zhongcai Network Post date May 5, 2022 — 17:46 Post Lock Read More Poinsettia (300723): Part of the company's actual controller's shares have been released from pledge and re-pledged CFi.CN Zhongcai Network Post date May 5, 2022 — 17:45 Post Lock Read More Fangyuan shares (688148): Fangyuan shares on the general election of the board of directors and the board of supervisors- CFi.CN Zhongcai Network Post date April 28, 2022 — 10:26 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine Post date April 27, 2022 — 13:26 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine. Post date April 27, 2022 — 13:16 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine – yqqlm Post date April 27, 2022 — 13:15 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Poinsettia: The company's vaccine pipeline products include 7 products including quadrivalent influenza vaccine and RSV vaccine Post date May 12, 2022 — 12:20 Post Lock Read More Poinsettia: The company's vaccine pipeline products include 7 products including quadrivalent influenza vaccine and RSV vaccine. Post date May 12, 2022 — 12:04 Post Lock Read More The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached) Post date May 11, 2022 — 20:43 Post Lock Read More Announcement at noon on May 9: A wholly-owned subsidiary of Poinsettia obtained the registration certificate of venlafaxine hydrochloride sustained-release capsules Post date May 9, 2022 — 12:09 Post Lock Read More Poinsettia (300723.SZ) has repurchased 5,081,700 shares at a cost of 146 million yuan Post date May 5, 2022 — 17:54 Post Lock Read More Poinsettia (300723.SZ) has repurchased 5,081,700 shares at a cost of 146 million yuan Post date May 5, 2022 — 17:50 Post Lock Read More Poinsettia (300723): Progress of share repurchase- CFi.CN Zhongcai Network Post date May 5, 2022 — 17:46 Post Lock Read More Poinsettia (300723): Part of the company's actual controller's shares have been released from pledge and re-pledged CFi.CN Zhongcai Network Post date May 5, 2022 — 17:45 Post Lock Read More Fangyuan shares (688148): Fangyuan shares on the general election of the board of directors and the board of supervisors- CFi.CN Zhongcai Network Post date April 28, 2022 — 10:26 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine Post date April 27, 2022 — 13:26 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine. Post date April 27, 2022 — 13:16 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine – yqqlm Post date April 27, 2022 — 13:15 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Poinsettia: The company's vaccine pipeline products include 7 products including quadrivalent influenza vaccine and RSV vaccine. Post date May 12, 2022 — 12:04 Post Lock Read More The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached) Post date May 11, 2022 — 20:43 Post Lock Read More Announcement at noon on May 9: A wholly-owned subsidiary of Poinsettia obtained the registration certificate of venlafaxine hydrochloride sustained-release capsules Post date May 9, 2022 — 12:09 Post Lock Read More Poinsettia (300723.SZ) has repurchased 5,081,700 shares at a cost of 146 million yuan Post date May 5, 2022 — 17:54 Post Lock Read More Poinsettia (300723.SZ) has repurchased 5,081,700 shares at a cost of 146 million yuan Post date May 5, 2022 — 17:50 Post Lock Read More Poinsettia (300723): Progress of share repurchase- CFi.CN Zhongcai Network Post date May 5, 2022 — 17:46 Post Lock Read More Poinsettia (300723): Part of the company's actual controller's shares have been released from pledge and re-pledged CFi.CN Zhongcai Network Post date May 5, 2022 — 17:45 Post Lock Read More Fangyuan shares (688148): Fangyuan shares on the general election of the board of directors and the board of supervisors- CFi.CN Zhongcai Network Post date April 28, 2022 — 10:26 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine Post date April 27, 2022 — 13:26 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine. Post date April 27, 2022 — 13:16 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine – yqqlm Post date April 27, 2022 — 13:15 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The good is coming! The Food and Drug Administration issued a request for comments. The market exclusivity period is up to 7 years, and the two types of new drugs will have a protection period (with shares attached) Post date May 11, 2022 — 20:43 Post Lock Read More Announcement at noon on May 9: A wholly-owned subsidiary of Poinsettia obtained the registration certificate of venlafaxine hydrochloride sustained-release capsules Post date May 9, 2022 — 12:09 Post Lock Read More Poinsettia (300723.SZ) has repurchased 5,081,700 shares at a cost of 146 million yuan Post date May 5, 2022 — 17:54 Post Lock Read More Poinsettia (300723.SZ) has repurchased 5,081,700 shares at a cost of 146 million yuan Post date May 5, 2022 — 17:50 Post Lock Read More Poinsettia (300723): Progress of share repurchase- CFi.CN Zhongcai Network Post date May 5, 2022 — 17:46 Post Lock Read More Poinsettia (300723): Part of the company's actual controller's shares have been released from pledge and re-pledged CFi.CN Zhongcai Network Post date May 5, 2022 — 17:45 Post Lock Read More Fangyuan shares (688148): Fangyuan shares on the general election of the board of directors and the board of supervisors- CFi.CN Zhongcai Network Post date April 28, 2022 — 10:26 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine Post date April 27, 2022 — 13:26 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine. Post date April 27, 2022 — 13:16 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine – yqqlm Post date April 27, 2022 — 13:15 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Announcement at noon on May 9: A wholly-owned subsidiary of Poinsettia obtained the registration certificate of venlafaxine hydrochloride sustained-release capsules Post date May 9, 2022 — 12:09 Post Lock Read More Poinsettia (300723.SZ) has repurchased 5,081,700 shares at a cost of 146 million yuan Post date May 5, 2022 — 17:54 Post Lock Read More Poinsettia (300723.SZ) has repurchased 5,081,700 shares at a cost of 146 million yuan Post date May 5, 2022 — 17:50 Post Lock Read More Poinsettia (300723): Progress of share repurchase- CFi.CN Zhongcai Network Post date May 5, 2022 — 17:46 Post Lock Read More Poinsettia (300723): Part of the company's actual controller's shares have been released from pledge and re-pledged CFi.CN Zhongcai Network Post date May 5, 2022 — 17:45 Post Lock Read More Fangyuan shares (688148): Fangyuan shares on the general election of the board of directors and the board of supervisors- CFi.CN Zhongcai Network Post date April 28, 2022 — 10:26 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine Post date April 27, 2022 — 13:26 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine. Post date April 27, 2022 — 13:16 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine – yqqlm Post date April 27, 2022 — 13:15 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Poinsettia (300723.SZ) has repurchased 5,081,700 shares at a cost of 146 million yuan Post date May 5, 2022 — 17:54 Post Lock Read More Poinsettia (300723.SZ) has repurchased 5,081,700 shares at a cost of 146 million yuan Post date May 5, 2022 — 17:50 Post Lock Read More Poinsettia (300723): Progress of share repurchase- CFi.CN Zhongcai Network Post date May 5, 2022 — 17:46 Post Lock Read More Poinsettia (300723): Part of the company's actual controller's shares have been released from pledge and re-pledged CFi.CN Zhongcai Network Post date May 5, 2022 — 17:45 Post Lock Read More Fangyuan shares (688148): Fangyuan shares on the general election of the board of directors and the board of supervisors- CFi.CN Zhongcai Network Post date April 28, 2022 — 10:26 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine Post date April 27, 2022 — 13:26 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine. Post date April 27, 2022 — 13:16 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine – yqqlm Post date April 27, 2022 — 13:15 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Poinsettia (300723.SZ) has repurchased 5,081,700 shares at a cost of 146 million yuan Post date May 5, 2022 — 17:50 Post Lock Read More Poinsettia (300723): Progress of share repurchase- CFi.CN Zhongcai Network Post date May 5, 2022 — 17:46 Post Lock Read More Poinsettia (300723): Part of the company's actual controller's shares have been released from pledge and re-pledged CFi.CN Zhongcai Network Post date May 5, 2022 — 17:45 Post Lock Read More Fangyuan shares (688148): Fangyuan shares on the general election of the board of directors and the board of supervisors- CFi.CN Zhongcai Network Post date April 28, 2022 — 10:26 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine Post date April 27, 2022 — 13:26 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine. Post date April 27, 2022 — 13:16 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine – yqqlm Post date April 27, 2022 — 13:15 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Poinsettia (300723): Progress of share repurchase- CFi.CN Zhongcai Network Post date May 5, 2022 — 17:46 Post Lock Read More Poinsettia (300723): Part of the company's actual controller's shares have been released from pledge and re-pledged CFi.CN Zhongcai Network Post date May 5, 2022 — 17:45 Post Lock Read More Fangyuan shares (688148): Fangyuan shares on the general election of the board of directors and the board of supervisors- CFi.CN Zhongcai Network Post date April 28, 2022 — 10:26 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine Post date April 27, 2022 — 13:26 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine. Post date April 27, 2022 — 13:16 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine – yqqlm Post date April 27, 2022 — 13:15 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Poinsettia (300723): Part of the company's actual controller's shares have been released from pledge and re-pledged CFi.CN Zhongcai Network Post date May 5, 2022 — 17:45 Post Lock Read More Fangyuan shares (688148): Fangyuan shares on the general election of the board of directors and the board of supervisors- CFi.CN Zhongcai Network Post date April 28, 2022 — 10:26 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine Post date April 27, 2022 — 13:26 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine. Post date April 27, 2022 — 13:16 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine – yqqlm Post date April 27, 2022 — 13:15 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Fangyuan shares (688148): Fangyuan shares on the general election of the board of directors and the board of supervisors- CFi.CN Zhongcai Network Post date April 28, 2022 — 10:26 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine Post date April 27, 2022 — 13:26 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine. Post date April 27, 2022 — 13:16 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine – yqqlm Post date April 27, 2022 — 13:15 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine Post date April 27, 2022 — 13:26 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine. Post date April 27, 2022 — 13:16 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine – yqqlm Post date April 27, 2022 — 13:15 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine Post date April 27, 2022 — 13:26 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine. Post date April 27, 2022 — 13:16 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine – yqqlm Post date April 27, 2022 — 13:15 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine. Post date April 27, 2022 — 13:16 Post Lock Read More Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine – yqqlm Post date April 27, 2022 — 13:15 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Poinsettia: The company's recombinant protein quadrivalent influenza vaccine under development has the same technical path as Sanofi's Flublok quadrivalent recombinant protein influenza vaccine – yqqlm Post date April 27, 2022 — 13:15 Post Lock Read More Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Researching and developing innovative new drugs and deploying diversified products, Yipinhong Pharmaceutical achieved a rapid growth of 57% in net profit attributable to the parent Post date April 25, 2022 — 13:16 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:20 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected Post date April 23, 2022 — 12:14 Post Lock Read More Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Poinsettia released its 2021 annual report: significant growth in revenue and net profit, and the future development of popular tracks can be expected – yqqlm Post date April 23, 2022 — 12:13 Post Lock Read More Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Poinsettia Announces 2021 Annual Equity Distribution Plan Post date April 20, 2022 — 22:02 Post Lock Read More
Caishen.CoCaishen.Co